Suchergebnisse - "Maartens, Gary"

PubPharm (63)

1

Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Brown, T. | Tang, L. | Omar, S. | +10

2

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB) : a phase 2, non-comparative, randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Griesel, R. | Zhao, Y. | Simmons, B. | +6

CommentIn: Lancet HIV. 2023 Jul;10(7):e422-e423. - PMID 37230100

3

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis : The LASER-TBM Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Davis, A. | Wasserman, S. | Stek, C. | +29

4

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT) : a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

enthalten in: Trials | 2022

von Van Rie, A. | De Vos, E. | Costa, E. | +24

5

Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa

enthalten in: The Journal of infectious diseases | 2022

von Haas, D. | Abdelwahab, M. | van Beek, S. | +11

6

Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline

enthalten in: Clinical pharmacokinetics | 2022

von Tanneau, L. | Karlsson, M. | Diacon, A. | +7

7

Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa : a retrospective cohort study

enthalten in: The Lancet. Infectious diseases | 2022

von Ndjeka, N. | Campbell, J. | Meintjes, G. | +12

CommentIn: Lancet Infect Dis. 2022 Jul;22(7):923-924. - PMID 35512717

8

Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB)

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Upton, C. | Steele, C. | Maartens, G. | +3

9

An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis : A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)

enthalten in: American journal of respiratory and critical care medicine | 2022

von Esmail, A. | Oelofse, S. | Lombard, C. | +21

CommentIn: Am J Respir Crit Care Med. 2022 May 15;205(10):1142-1144. - PMID 35320062

10

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis : a cross-sectional and longitudinal study

enthalten in: The Lancet. Infectious diseases | 2022

von Ismail, N. | Omar, S. | Moultrie, H. | +21

CommentOn: Lancet Infect Dis. 2022 Apr;22(4):432-433. - PMID 34780707

1
2
3
4
5
6
7
Nächster »
[7]